GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neola Medical AB (OSTO:NEOLA) » Definitions » Debt-to-Asset

Neola Medical AB (OSTO:NEOLA) Debt-to-Asset : 0.00 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Neola Medical AB Debt-to-Asset?

Neola Medical AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. Neola Medical AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. Neola Medical AB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was kr83.07 Mil. Neola Medical AB's debt to asset for the quarter that ended in Mar. 2024 was 0.00.


Neola Medical AB Debt-to-Asset Historical Data

The historical data trend for Neola Medical AB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neola Medical AB Debt-to-Asset Chart

Neola Medical AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial - - - - -

Neola Medical AB Quarterly Data
Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Neola Medical AB's Debt-to-Asset

For the Medical Devices subindustry, Neola Medical AB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neola Medical AB's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neola Medical AB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Neola Medical AB's Debt-to-Asset falls into.



Neola Medical AB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Neola Medical AB's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Neola Medical AB's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neola Medical AB  (OSTO:NEOLA) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Neola Medical AB Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Neola Medical AB's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Neola Medical AB (OSTO:NEOLA) Business Description

Traded in Other Exchanges
N/A
Address
Scheelevägen 27, Ideon Science Park, Lund, SWE, 223 63
Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.

Neola Medical AB (OSTO:NEOLA) Headlines

No Headlines